Regeneron Pharmaceuticals Inc (REGN)

$619.45-0.33%

Spriggl Score: Good— see the number + sub-scores with a free Spriggl account

Last 30 trading days

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and …

Sector:: Healthcare
Industry:: Biotechnology
Market Cap:: $75.5B

Recent dividends

20 May 2026$0.94
20 Feb 2026$0.94
20 Nov 2025$0.88

Get the full Spriggl analysis — free

Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Regeneron Pharmaceuticals Inc and 1,600+ UK and US stocks.

Start free